Loading company…
Dublin medtech developing the ProVee stent to relieve urinary symptoms caused by enlarged prostates without surgery.
ProVerum Limited develops medical devices for lower urinary tract symptoms caused by benign prostatic hyperplasia. Its flagship ProVee stent has a 3-D geometry matched to prostate anatomy and is sold to hospitals and urology clinics, mainly in the US, Canada and Ireland. Founded in 2016 in Dublin, Ireland, by Conor Harkin, it raised EUR 68 million in Series B funding in August 2025, led by MVM Partners, with OrbiMed Advisors and Ireland Strategic Investment Fund also investing. Its 2021 EBITDA was EUR -4,097,937.50.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in